Niagen Bioscience posts record Q3 revenue, boosted by Tru Niagen and new partnerships. Read here for an investment analysis of NAGE stock.

Travelers returning from Europe frequently report a curious experience. They eat pasta, bread, and rich cuisine, but somehow ...

Scholar Rock Holding Company ( SRRK) is a Boston-based, clinical-stage biotech that was founded in 2012, focusing on ...

A San Antonio woman has spent the last decade developing a product and creating a company that aims to clearly label IV ...

The practice of routinely maintaining PIVC access has not only benefits but also risks. It’s due for a mindset shift, with ...

The cohesin subunit Scc1 returns and reconstitutes the complex with Smc1–Smc3 in late mitosis upon DNA double-strand breaks, although it does not participate in homologous recombination-driven MAT ...

Whether infection of cells by individual virions occurs randomly or if there is some form (s) of competition or cooperativity between individual virions remains largely unknown for most virus-cell ...

An application for subcutaneous induction dosing with Leqembi Iqlik was initiated in the US Net revenues amounted to SEK 133.3 M (76.6), of which SEK 117.2 M (69.8) in royalties for Leqembi and SEK 8.

Beyond Meat, Inc. (NASDAQ: BYND) (“Beyond Meat” or “the Company”), a leader in plant-based meat, today reported financial results for its third quarter ended September 27, 2025. Third Quarter 2025 ...

While many hospitals require an IV during labor, routine intravenous lines may not always be necessary. Here's why they might be placed.

Artiva remains on track to share initial clinical response data and conduct U.S. Food and Drug Administration (FDA) regulatory interactions to align on pivotal trial design for AlloNK in refractory ...

Authorization Received from UK and EU Authorities to Activate ex-US Clinical Trial Sites Supporting the Ongoing Patient Enrollment of FT819, an ...